Astaxanthin
(as' × tä × zan'× thin)
What is Astaxanthin?
Astaxanthin is the main carotenoid pigment found in aquatic animals.
This red-orange pigment is closely related to other well-known carotenoids
such as beta-carotene or lutein, but has a stronger antioxidant activity
(10 times higher than beta-carotene). Studies suggest that Astaxanthin can
be 1000 times more effective as an antioxidant than vitamin E.
In many of the aquatic animals where it can be found, Astaxanthin has
a number of essential biological functions, ranging from protection against
oxidation of essential polyunsaturated fatty acids, protection against
UV-light effects, pro-vitamin A activity and vision, immune response,
pigmentation, and communication, to reproductive behavior and improved
reproduction.
In species such as salmon or shrimp, Astaxanthin is even
considered as essential to normal growth and survival, and has been
attributed vitamin-like properties. Some of these unique properties
have also been found to be effective in mammals and open very promising
possibilities for nutraceutical and pharmaceutical applications of Astaxanthin in humans.
Where Is Astaxanthin Found in Nature?
It can be found in many of our favorite
seafood such as salmon, trout, red seabream, shrimp, lobster and fish eggs.
It is also found in a number of bird species. Astaxanthin cannot be synthesized
by animals and must be provided in the diet, as is the case with other carotenoids.
While fish such as salmon are unable to convert other dietary carotenoids into Astaxanthin,
some species such as shrimp have a limited capacity to convert closely related
dietary carotenoids into Astaxanthin, although they will benefit strongly from being
fed Astaxanthin directly.
Mammals are also unable to synthesize Astaxanthin.
Some microorganisms can be quite rich in Astaxanthin. Ubiquitous micro-algae,
Haematococcus pluvialis is believed to be the organism, which can accumulate
the highest levels of Astaxanthin in nature.
The function of Astaxanthin
The function of Astaxanthin appears to be to protect the algae from adverse environment changes,
such as increased UV-light photoxidation and evaporation of the water
pools in which it lives.
Haematococcus algae can accumulate as high
as 10 to 30 g of Astaxanthin per kg of dry biomass. This level is 1,000
to 3,000 fold higher than in salmon fillets! Some strains have even been
observed to accumulate as much as 70 to 80 g of Astaxanthin per kg of dry biomass.
More on Astaxanthin?
Astaxanthin is a red pigment occurring naturally in a variety of
living organisms. Although the word Astaxanthin may not be commonly
encountered in everyday speech, the pigment itself is found in many
human foods, and you are quite likely to be consuming it in your diet
already. Most crustaceans, including shrimp, crawfish, crabs and lobster,
are tinted red by accumulated Astaxanthin. The coloration of fish is
often due to Astaxanthin; the pink flesh of a healthy wild salmon is
a conspicuous example. In commercial fish and crustacean farms,
Astaxanthin is commonly added to feeds in order to make up for the
lack of a natural dietary source of the pigment (Torrissen et al. 1989).
Not only does Astaxanthin provide for pigmentation in these farmed
animals, it also has been found to be essential for their proper
growth and survival (Torrissen and Christiansen 1995).
Astaxanthin is one of a group of natural pigments known as carotenoids.
In nature, carotenoids are produced principally by plants and their
microscopic relatives, the microalgae. Animals cannot synthesize
carotenoids de novo, thus ultimately they must obtain these pigments
from the plants and algae that support their food chains (Britton et al. 1995).
Commercial production of Astaxanthin from the microalga Haematococcus pluvialis
is a growing business worldwide, primarily due to the rapid growth of this microorganism
and its high Astaxanthin content. Other commercial ventures for natural Astaxanthin
production utilize fermentation of the pink yeast Xanthophyllomyces dendrorhous
or extraction of the pigment from by-products of crustacea such as the Antarctic
krill (Euphausia superba). In addition to production from natural sources,
Astaxanthin may be chemically synthesized, and synthetic Astaxanthin is the
major form currently being used in fish feeds (McCoy 1999).
The Astaxanthin molecule is similar to that of the familiar carotenoid
beta-carotene, but the small differences in structure confer large
differences in the chemical and biological properties of the two
molecules. In particular, Astaxanthin exhibits superior antioxidant
properties to beta-carotene in a number of in vitro studies (Terao
1989; Miki 1991; Palozza and Krinsky 1992; Lawlor and O'Brien 1995).
While the positive effects of Astaxanthin on farmed fish and crustaceans
have been recognized for years, the potential benefits of this powerful
antioxidant to human health are only now being revealed.
More on Astaxanthin: In the Pink
We accept the vibrancy of life around us as normal daily occurrences.
We walk through a bird aviary and ooh and ahh at feathers of flamingos.
We enjoy the delectable pink taste of shrimp or salmon without understanding
that within that pink nestles an antioxidant ready to combat the free radicals
that assault our bodies daily. Astaxanthin is that same red-orange carotenoid
pigment found in aquatic animals or in the feathers of the more exotic bird variety.
Not only does it add a splash of color to life, it also ranks as one of the strongest
antioxidants known to man.
It actually beats, ten times, beta-carotene's strength and
research has shown it to be more effective than both vitamin C and E. (Jyonouchi, H.,
L. Zhang, M. Gross, and Y. Tomita. 1994 Immunomodulating actions of carotenoids:
Enhancement of in vivo and in vitro antibody production to T-dependent antigens.
Nutr. Cancer 21:47-58)
Antioxidants are absolutely necessary in maintaining a healthy body.
Within our bodies are little rascals known as free radicals. Free radicals are
highly unstable molecules due to their lack of one unpaired electron, making
them "jealous" of and dangerous to other molecules. This "envy" motivates
them to rip an electron from a stable molecule, causing a once healthy
molecule to become unsteady. Once a free radical damages a molecule,
that molecule follows suit and damages other molecules starting a
vicious chain of events. Some doctors and scientists theorize that free radicals
promote aging and all its effects. Unfortunately, we can't stop free radicals
since they're oxygen based.
Every time we breathe, oxygen molecules pass into
our lungs, travel through our blood stream, and are delivered to cells that
consume oxygen for energy and for building proteins. But what's good for the
goose, is not always good for the gander and the highly reactive oxygen can
throw some molecules off, leaving them with an extra or stripped of one
electron. If this only happened once in a while, free radicals would not
be so worrisome but, unluckily for us and our cells and DNA, each cell
can receive 1,000 hits by free radical activity in a 24-hour period!
Since we need to breathe and oxygen is essential, doctors and scientists
have discovered that nature has developed a free radical clean-up crew referred
to as antioxidants. Astaxanthin is an antioxidant that goes the extra mile.
Since it has a low molecular weight, it can pass the blood-brain barrier
where it works it's antioxidant magic on the eye, brain, and central
nervous system. It also has a longer life span and is resistant to
damage, allowing it a longer amount of time to escort free radicals
from cells to other antioxidants like vitamin C.
Looking at past
studies, it is clear that cartenoids can influence different aspects
of the immune system. They can stimulate the T-helper cells, improve
rejection of foreign tissue, and increase the action of natural killer
cells that destroy tumor cells and fungi. Our immune systems are constantly
bombarded with foreign and harmful substances, and any assistance it can
receive from an antioxidant is always welcome. When all of these factors
add up, Astaxanthin proves itself to be a powerful ally to the body.
So do yourself a favor, add a splash of color to your life by supplementing
your diet with food containing Astaxanthin from the antioxidant's natural
occurring and strongest source, the algae Haematococcus, a fresh water microalgae.
It's a natural source to saving your life and keeping you healthy.
Frequently Asked Questions
1. What is Astaxanthin?
Astaxanthin is a member of the carotenoid family.
These molecules are associated with many of the
colors that you see in leaves, flowers and fruit.
They are one of the most abundant molecules in the
world and give nature its wide variety of colors. Carotenoids
have a long structure called the polyene system and may also have
ring groups at one or either end.
The differences in the polyene and ring structures are what varies
the carotenoids and their corresponding colors due to different
light absorbencies. Astaxanthin is a red pigment and the predominant
carotenoid of most crustacean species. Interestingly, when
Astaxanthin binds to different protein, it can appear green,
yellow, blue or brown. When these "carotenoproteins" are
denatured by cooking, Astaxanthin is released and the red
color becomes apparent again.
2. What types of Astaxanthin are currently available?
At this time, the primary source of Astaxanthin and carotenoids
are mostly synthetic forms produced by chemical means. There are also
natural sources available from processed krill, crawfish and
yeast and from Haematococcus algae, the most concentrated source of
natural Astaxanthin that is available.
3. What are the benefits of using an algae source for Astaxanthin
compared to the other natural forms?
The krill, crawfish and Phaffia sources contain low concentrations of Astaxanthin.
Feeds may require so much addition of these products for effective
pigmentation that it adds unwanted bulk and ash, decreases
palatability, and alters the nutrient balance of the diet.
The Astaxanthin derived from Haematococcus algae is the most
concentrated source of natural Astaxanthin that is available.
Research
There is a large body of research available on Astaxanthin. Several scientific papers have been written on medical and neutraceutical applications of Astaxanthin. Medical researchers have shown that ASTAXANTHIN may have significant pharmaceutical applications. In-vitro experiments, in-vivo pre-clinical studies and early-stage clinical trials have clearly indicated the possibility that ASTAXANTHIN itself, or in conjunction with other components, behaves like a prophylactic and curing agent against various diseases and health conditions (See Tables 1 and 2).
TABLE 1. SELECTED PATENTS ON ASTAXANTHIN APPLICATIONS IN HEALTH AND NUTRITION
PATENT NUMBER - COMPANY - PATENT TITLE
EP0786990 - US NUTRACEUTICALS USE OF ASTAXANTHIN FOR RETARDING AND AMELIORATING CENTRALNERVOUS SYSTEM AND EYE DAMAGE
EP1217996 - ASTACAROTENE USE OF ASTAXANTHIN FOR TREATMENT OF AUTOIMMUNE DISEASES,CHRONIC VIRAL AND INTRACELLULAR BACTERIAL INFECTIONS
US6475547 - ASTACAROTENE Immunoglobulin-rich milk, production and use thereof
WO0023064 - ASTACAROTENE TREATMENT OF DYSPEPSIA
US6410602 - ASTACAROTENE Method of increasing the production and improving the quality of semen
US6335015 - ASTACAROTENE Method of the prophylactic treatment of mastitis
US6262316 - ASTACAROTENE Oral preparation for the prophylactic and therapeutic treatment ofHELICOBACTER SP. infection
US6245818 - ASTACAROTENE Medicament for improvement of duration of muscle function or treatmentof muscle disorders or diseases
US6054491 - ASTACAROTENE Agent for increasing the production of/in breeding and production mammals
US5744502 - ASTACAROTENE Method for increasing the production of/in breeding and productionA NIMALS IN the poultry industry
US6433025 - CYANOTECH Method for retarding and preventing sunburn by UV light
US6344214 - CYANOTECH Method for retarding and ameliorating fever blisters and canker sores
US6258855 - CYANOTECH Method of retarding and ameliorating carpal tunnel syndrome
EP1283038 - SUNTORY LTD COMPOSITIONS NORMALIZING CIRCADIAN RHYTHM
WO03013556 - ITAKURA HIROSHIGE MEDICINAL COMPOSITIONS HAVING EFFECTS OF AMELIORATINGEYE DISEASES AND HOLDING EYE FUNCTIONS
WO03003848 - AANESEN BERIT ANNIE THE USE OF DI-ESTERS OF ASTAXANTHIN FOR ENHANCING THE GROWTH OFFARMED FISH
WO02094253 - FUJI CHEM IND CO AGENTS FOR RELIEVING EYE CONTROLLING FUNCTION ERROR
KR2000045197 - PACIFIC CO LTD HEALTHY NUTRITION COMPOSITION CONTAINING CHITOSAN OLIGOSACCHARIDEAND ASTAXANTHIN
WO02058683 - LYCORED CAROTENOIDS AS ANTI-HYPERTENSION AGENTS
NZ299641 - SUNTORY AND ITANO Use of astaxanthin in pharmaceuticals for treating stress
US6277417 - TRIARCO Method OF INHIBITING 5alpha-reductase with astaxanthin
US2003/778304 - anderson AND PETTERSON METHOD OF INHIBITING THE EXPRESSION OF INFLAMMATORY CYTOKINES AND CHEMOKINES
JP10276721 - SUNTORY AND ITANO ASTAXANTHIN-CONTAINING FOOD OR DRINK
TABLE 2. - ELECTED ARTICLES ON ASTAXANTHIN APPLICATIONS FOR HUMAN AND MAMMALIAN HEALTH
Conditions and reference numbers found next in References
Central nervous system and neurodegradative diseases - 6
Eye health - 6, 23 - 26
Joint health, muscle endurance - 27, 28
Inflammation and immune system - 5, 29 - 46
Cardiovascular, heart, Lipid peroxidation and blood - 47 - 53
Cancer - 49, 54 - 65
Fertlity - 66, 67
Sunburn and skin health, anti-aging and anti-wrinkling - 26, 68 - 72
Benign prostatic hyperplasia (BPH) - 73
REFERENCES
1-Boussiba
S.; Vonshak A.; Cohen Z.; Richmond A. (1997)
A procedure for large scale production of Astaxanthin from Haematococcus.
WO 97/28274.
2- Papas, A.M. (1999)
Antioxidant Status, Diet, Nutrition, and Health. CRC Press.
3-
Palozza, P. and Krinsky, N.I. (1992)
Astaxanthin and canthaxanthin are potent antioxidants in a membrane
model. Arch. Biochem. Biophys. 297: 291–295.
4-
Naguib, Y.M.A. (2000)
Antioxidant activities of astaxanthin and related carotenoids.
J. Agric. Food Chem. 48: 1150–1154.
5- Chew B.P. and Park J.S., (October 2003)
Dissertation in Supply Side West. Las Vegas.
6-
Tso, M.O.M. and Lam, T-T. (1996)
Method of Retarding and Ameliorating Central Nervous System
and Eye Damage. Assigned to U. S. Nutraceuticals. U.S. Patent #5527533.
7-
Facchinetti F.; Dawson VL.; Dawson TM. (1998)
Free radicals as mediators of neuronal injury. Cell Mol Neurobiol.18(6):667-82.
8-
Lorenz, R.T. and Cysewski, G.R. (2000)
Commercial potential for Haematococcus microalgae as a natural
source of astaxanthin. Trends in Biotechnol. 18: 160–167.
9
- Guerin, M.; Huntley M. E.; and Olaizola M. (2003)
Haematococcus astaxanthin: applications for human health and
nutrition. Trends in Biotechnol. 21: 210-216.
10-
Shibata A.; Kiba Y.; Akati N.; Fukuzawa K.; Terada H. (2001)
Molecular characteristics of astaxanthin and beta-carotene in
the phospholipid monolayer and their distributions in the phospholipid
bilayer. Chem Phys Lipids113(1-2): 11-22.
11-
Goto S.; Kogure K.; Abe K.; Kimata Y.; Kitahama K.; Yamashita E.;
Terada H. (2001)
Efficient radical trapping at the surface and inside the phospholipid
membrane is responsible for highly potent antiperoxidative activity
of the carotenoid astaxanthin. Biochim Biophys Acta1512(2): 251-8.
12-
Oshima S.; Ojima F.; Sakamoto H.; Ishiguro Y.; Terao J. (1993)
Inhibitory effect of beta-carotene and astaxanthin
on photosensitized oxidation of phospholipid bilayers. J Nutr Sci
Vitaminol (Tokyo) 39(6): 607-15.
13-
Kurashige M.; Okimasu E.; Inoue M.; Utsumi K. (1990)
Inhibition of oxidative injury of biological membranes
by astaxanthin. Physiol Chem Phys Med NMR 22(1): 27-38.
14
- Nakagawa K.; Kang SD.; Park DK.; Handelman GJ.; Miyazawa T. (1997)
Inhibition of beta-carotene and astaxanthin of NADPH-dependent microsomal
phospholipid peroxidation. J Nutr Sci Vitaminol (Tokyo) 43(3): 345-55.
15– Bahner, B. (1993)
Beta –carotene use grows; natural sector in flux. Chemical
Market Reporter 244:26-27.
16- Cyanotech Corporation –
Technical paper available at: http://www.cyanotech.com/pdfs/axbul60.pdf
17 - Mera Pharmaceuticals (1999)
Haematococcus pluvialis and astaxanthin safety for human consumption.
Technical Report TR.3005.001
available at http://www.astafactor.com/techreports/tr3005-001.htm
18 – La Haye - US Nutraceuticals
technical paper available at: http://www.lahaye.com/safety.html
19-
Spiller GA.; Dewell A. (2003)
Safety of an Astaxanthin-Rich Haematococcus pluvialis Algal
Extract: A Randomized Clinical Trial. J Med Food 6(1): 51-6.
20-
Turujman, S.A. et al. (1997)
Rapid liquid chromatographic method to distinguish wild salmon
from aquacultured salmon fed synthetic astaxanthin. J. AOAC Int.
80: 622–632.
21-
Mercke Odeberg J.; Lignell A.; Pettersson A.; Hoglund P. (2003)
Oral bioavailability of the antioxidant astaxanthin in humans
is enhanced by incorporation of lipid based formulations. Eur J
Pharm Sci 19(4): 299-304.
22-
Clark RM.; Yao L.; She L.; Furr HC. (2000)
A comparison of lycopene and astaxanthin absorption from corn
oil and olive oil emulsions. Lipids 35(7): 803-6.
23
- Snodderly D.M. (1995)
Evidence for protection against age related macular degeneration
by caretonoids and antioxidant vitamins. Amer J. Clinical Nutrition.
63(s):1448S-1461S.
24-
Ohgami K.; Shiratori K.; Kotake S.; Nishida T.; Mizuki N.; Yazawa
K.; Ohno S. (2003)
Effects of astaxanthin on lipopolysaccharide-induced
inflammation in vitro and in vivo. Invest Ophthalmol Vis Sci . 44(6):
2694-701.
25
- Waagbo R.; Hamre K.; Bjerkas E.; Berge R.; Wathne E.; Lie O.;
Torstensen B. (2003)
Cataract formation in Atlantic salmon, Salmo salar L., smolt
relative to dietary pro- and antioxidants and lipid level . J Fish
Dis. 26(4): 213-29.
26-
O'Connor I.; O'Brien N. (1998)
Modulation of UVA light-induced oxidative stress by beta-carotene,
lutein and astaxanthin in cultured fibroblasts. J Dermatol Sci .
16(3): 226-30.
27 - Malmsten C. (1998)
Dietary supplementation with astaxanthin rich algal meal improves
muscle endurance – a double blind study on male students.
Unpublished study from the Karolinska Institute. Gustavberg, Sweden.
28- Lignell
A. (2001)
Medicament for improvement of duration of muscle function or
treatment of muscle disorders or diseased. US patent # 6,245,818
Astacarotene AB Sweden.
29-
Bennedsen, M. et al. (1999)
Treatment of H. pylori infected mice with antioxidant astaxanthin
reduces gastric inflammation, bacterial load and modulates cytokine
release by splenocytes. Immunol. Lett. 70: 185–189.
30-
Wang X.; Willen R.; Wadstrom T. (2000)
Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter
pylori infection in BALB/cA mice. Antimicrob Agents Chemother 44(9):
2452-7.
31-Lignell,
A. (1998)
Treatment of Dyspepsia, Patent no. WO 00/23064
32-
Anderson T.; Pettersson S. (2001)
Method of inhibiting the expression of inflammatory cytokines. Patent
no. WO 0172296.
33-
Lorenz T. et al. (2000)
Method of retarding Ameliorating Carpel tunnel syndrome, US Patent
#. 6,258,855.
34-
Hughes D.A. (1999)
Effects of dietary antioxidants on the immune function of the middle
aged. Proc. Nutr. Soc 58(1): 79-84.
35- Lignell
A. (2001)
Use of xanthophylls, Astaxanthin e.g. for the treatment of autoimmune
diseases, chronic viral and intracellular bacterial infections.
Patent # WO 01/24787.
36- Lignell
A. et al. (1998)
Method for the prophylactic treatment of mastitis. WO99/30701.
37-
Jyonouchi, H. et al. (1995)
Effect of carotenoids on in vitro immunoglobulin production by human
peripheral blood mononuclear cells: astaxanthin, a carotenoid without
vitamin A activity, enhances in vitro immunoglobulin production
in response to a T-dependent stimulant and antigen. Nutr. Cancer
23: 171–183.
38-
Lee SJ.; Bai SK.; Lee KS.; Namkoong S.; Na HJ.; Ha KS.; Han JA.;
Yim SV.; Chang K.; Kwon YG.; Lee SK.; Kim YM. (2003)
Astaxanthin inhibits nitric oxide production and inflammatory gene
expression by suppressing I(kappa)B kinase-dependent NF-kappaB activation.
Mol Cells Korea 16(1): 97-105.
39- Chew BP.; Wong MW.; Park JS.; Wong TS. (1999)
Dietary beta-carotene and astaxanthin but not canthaxanthin stimulate
splenocyte function in mice. Anticancer Res. 19(6B): 5223-7.
40-
Jyonouchi H.; Zhang L.; Tomita Y. (1993)
Studies of immunomodulating actions of carotenoids. II. Astaxanthin
enhances in vitro antibody production to T-dependent antigens without
facilitating polyclonal B-cell activation. Nutr Cancer 19(3): 269-80.
41-
Jyonouchi H.; Hill RJ.; Tomita Y.; Good RA. (1991)
Studies of immunomodulating actions of carotenoids. I. Effects of
beta-carotene and astaxanthin on murine lymphocyte functions and
cell surface marker expression in in vitro culture system. Nutr
Cancer 16(2): 93-105.
42-
Akyon Y. (2002 )
Effect of antioxidants on the immune response of Helicobacter pylori.
Clin Microbiol Infect. 8(7): 438-41.
43-
Okai Y.; Higashi-Okai K. (1996)
Possible immunomodulating activities of carotenoids in in vitro
cell culture experiments. Int J Immunopharmacol 18(12): 753-8.
44-
Jyonouchi H.; Sun S.; Mizokami M.; Gross MD. (1996)
Effects of various carotenoids on cloned, effector-stage T-helper
cell activity. Nutr Cancer 26(3): 313-24.
45-
Jyonouchi H.; Sun S.; Tomita Y.; Gross MD. (1995)
Astaxanthin, a carotenoid without vitamin A activity, augments antibody
responses in cultures including T-helper cell clones and suboptimal
doses of antigen. J Nutr 125(10): 2483-92.
46-
Jyonouchi H.; Zhang L.; Gross M.; Tomita Y. (1994)
Immunomodulating actions of carotenoids: enhancement of in vivo
and in vitro antibody production to T-dependent antigens. Nutr Cancer
21(1): 47-58.
47- Murillo E. (1992)
Cholesterolemic effects of canthaxanthin & astaxanthin in rats.
Arc Latinoam Nutr. 42: 409-13.
48-
Iwamoto T.; Hoosoda K.; Hirano R.; Kurata H.; Matsumoto A.; Miki
W.; Kamiyama M.; Itakaru H.; Yamamoto S.; Kondo K. (2001)
Inhibition of low-density lipoprotein oxidation by astaxanthin.
J Atheroscler Thromb 7: 216-22
49-
Zhang LX.; Cooney RV.; Bertram JS. (1991)
Astaxanthin limits exercise-induced skeletal and cardiac muscle
damage in mice. in C3H/10T1/2 cells: relationship to their cancer
chemopreventative action. Carcinogenesis 12(11): 2109-14.
50-
Aoi W.; Naito Y.; Sakuma K.; Kuchide M.; Tokuda H.; Maoka T.; Toyokuni
S.; Oka S.; Yasuhara M.; Yoshikawa T. (2003)
Astaxanthin limits exercise-induced skeletal and cardiac muscle
damage in mice. Antioxid Redox Signal 5(1): 139-44.
51-
Kang JO.; Kim SJ.; Kim H. (2001)
Effect of astaxanthin on the hepatotoxicity, lipid peroxidation
and antioxidative enzymes in the liver of CCl4-treated rats. Methods
Find Exp Clin Pharmacol. 23(2): 79-84.
52-
Murillo E. (1992)
Hypercholesterolemic effect of canthaxanthin and astaxanthin in
rats. Arch Latinoam Nutr 42(4): 409-13.
53-Rengel
D.; Diez-Navajas A.; Serna-Rico A.; Veiga P.; Muga A.; Milicua JC.
(2000) Exogenously incorporated ketocarotenoids in
large unilamellar vesicles. Protective activity against peroxidation.
Biochim Biophys Acta 1463(1): 179-87.
54-
Jyonouchi H.; Sun S.; Iijima K.; Gross MD. (2000)
Antitumour activity of astaxanthin and its mode of action. Nutr
cancer 36(1): 59-65.
55-
Kurihara H.; Koda H.; Asami S.; Kiso Y.; Tanaka T. (2002)
Contribution of the anti oxidative property of astaxanthin to its
protective effect on the promotion of cancer metastasis in mice
treated with resistant stress. Life Sci. 70(21): 2509-20.
56-
Tanaka T.; Makita H.; Ohnishi M.; Mori H.; Satoh K.; Hara A. (1995)
Chemoprevention of rat oral carcinogenesis by naturally occurring
xanthophylls, astaxanthin and canthaxanthin. Cancer Res. 55 (18):
4059-4064.
57-
Tanaka T.; Morishita Y.; Suzui M.; Kojima T.; Okumura A.; Mori H.
(1994) Chemoprevention of mouse urinary bladder carcinogenesis
by the naturally occurring carotenoid astaxanthin. Carcinogenesis
15(1): 15-19.
58-
Tanaka T.; Kawamori T.; Ohnishi M.; Makita H.; Mori H.; Satoh K.;
Ha A. (1995) Suppression of azoxymethane-induced rat
colon carcinogenesis by dietary administration of naturally occurring
xanthophylls astaxanthin and canthaxanthin during the postinitiation
phase. Carcinogenesis 16(12): 2957-63.
59-
Rousseau EJ.; Davison AJ.; Dunn B. (1992)
Protection by beta-carotene and related compounds against oxygen-mediated
cytotoxicity and genotoxicity: implications for carcinogenesis and
anticarcinogenesis. Free Radic Biol Med 13(4): 407-33.
60-
Kozuki Y.; Miura Y.; Yagasaki K. (2000)
Inhibitory effects of carotenoids on the invasion of rat
ascites hepatoma cells in culture. Cancer Lett 151(1): 111-5
61-
Gradelet S.; Le Bon AM.; Berges R.; Suschetet M.; Astorg P. (1998)
Dietary carotenoids inhibit aflatoxin B1-induced liver preneoplastic
foci and DNA damage in the rat: role of the modulation of aflatoxin
B1 metabolism. Carcinogenesis (3): 403-11.
62-
Black HS. (1998)
Radical interception by carotenoids and effects on UV carcinogenesis.
Nutr Cancer 31(3): 212-7.
63
- Nishino H.; Murakosh M.; Ii T.; Takemura M.; Kuchide M.; Kanazawa
M.; Mou XY.; Wada S.; Masuda M.; Ohsaka Y.; Yogosawa S.; Satomi
Y.; Jinno K. (2002)
Carotenoids in cancer chemoprevention. Cancer Metastasis Rev. 21(3-4):
257-64.
64-
Li Z.; Wang Y.; Mo B. (2002)
The effects of carotenoids on the proliferation of human breast
cancer cell and gene expression of bcl-2. Zhonghua Yu Fang Yi Xue
Za Zhi. 36(4): 254-7.
65-
Chew BP.; Park JS.; Wong MW.; Wong TS. (1999)
A comparison of the anticancer activities of dietary beta-carotene,
canthaxanthin and astaxanthin in mice in vivo. Anticancer Res 19(3A):
1849-53.
66-
Hansen KB.; Tauson AH.; Inborr J. (2001)
Effect of supplementation with the antioxidant astaxanthin on reproduction,
pre-weaning growth performance of kits and daily milk intake in
mink. J Reprod Fertil Suppl. 57: 331-4.
67-
Lignell et al. (1998)
Method of increasing the production and improving the quality of
semen. WO99/29313.
68-
Lyons NM.; O'Brien NM. (2002)
Modulatory effects of an algal extract containing astaxanthin on
UVA-irradiated cells in culture. J Dermatol Sci (1): 73-84.
69-
Savoure N.; Briand G.; Amory-Touz MC.; Combre A.; Maudet M.; Nicol
M. (1995) Vitamin A status and metabolism of cutaneous
polyamines in the hairless mouse after UV irradiation: action of
beta-carotene and astaxanthin. Int J Vitam Nutr Res 65(2): 79-86.
70- Skin et al. (2001)
Effects of astaxanthin from Haematococcus pluvialis on human skin.
Fragrance Journal 12: 98-103.
71- Yamahita et al, (1995)
Suppression of post-UVB hyperpigmention by topical astaxanthin from
krill. Fragrance Journal 14: 180-185.
72-
R. Todd Lorenz.
Method for retarding and preventing sunburn by UV light. R. Patent
no. US 6,433,025 B1 Cyanotech corporation.
73-
Anderson, M. (2001)
Method of Inhibiting 5-a Reductase with Astaxanthin to Prevent and
Treat Benign Prostate Hyperplasia (BPH) and Prostate Cancer in Human
Males. US Patent #6277417.
74- Østerlie M.; Bjerkeng
B.; Liaaen-Jensen S. (1999)
On bioavailability and deposition of bent Z-isomers of astaxanthin.
In: Pigments in Food Technology. Proceedings of 1st International
Congress PFT (Minguez Mosquera, M. I., Galan, M. J. & Mendez,
D. H., eds) pp. 157-161. International Congress on Pigments in Food
Technology, Sevilla, Spain
75- Østerlie M.; Bjerkeng B.; Liaaen-Jensen
S. (1999)
Blood appearance and distribution of astaxanthin E/Z isomers among
plasma lipoproteins in humans administered in a single meal with
astaxanthin. Abstract 2A-13. Presented at the 12th International
Symposium on Carotenoids in Cairns, Queensland, Australia, July
18-23, 1999.
76
- Østerlie M.; Bjerkeng B.; Liaaen-Jensen, S. (2000)
Plasma appearance and distribution of astaxanthin E/Z and R/S isomers
in plasma lipoproteins of men after single dose administration of
astaxanthin. J. Nutr. Biochem. 11: 482-490.
Additional References:
Britton, G., S. Liaaen-Jensen, and H. Pfander. (1995) Carotenoids today and
challenges for the future. In: Britton, G., S. Liaaen-Jensen, and H. Pfander [eds],
Carotenoids vol. 1A: Isolation and Analysis. Basel: Birkhäuser.
Lawlor, S. M. and O'Brien, N. M. (1995) Astaxanthin: antioxidant effects in chicken
embryo fibroblasts. Nutr. Res., 15:1695-1704.
McCoy, M. (1999) Astaxanthin market a hard one to crack. Chem.& Eng. News, 77: 15-17.
Miki, W. (1991) Biological functions and activities of animal carotenoids. Pure Appl.
Chem., 63(1):141-146.
Palozza, P. and Krinsky, N. I. (1992) Astaxanthin and canthaxanthin are potent
antioxidants in a membrane model. Arch. Biochem. Biophys., 297:291-295.
Terao, J. (1989) Antioxidant activity of beta-carotene-related carotenoids in
solution. Lipids, 24: 659-661.
Torrissen, O. J. and Christiansen, R. (1995) Requirements for carotenoids in
fish diets. J. Appl. Ichthyol., 11:225-230.
Torrissen, O.J., R.W. Hardy, and K.D. Shearer. (1989) Pigmentation of
salmonids--carotenoid deposition and metabolism. CRC Crit. Rev. Aquat. Sci., 1: 209-225.
FDA Disclaimer
- Statements on this website have not been evaluated by the Food and Drug Administration. None of the products / services offered on this Web site are intended to diagnose, treat, cure or prevent any disease.